ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2403

Sleep Disruption in Children with Chronic Pain

Cara Hoffart1, Santana Fortney2 and Dustin Wallace3, 1Rheumatology and Pain Management, Children's Mercy Hospital, Kansas City, MO, 2Children's Mercy Hospital, Kansas City, MO, 3Integrative Pain Management and Developmental and Behavioral, Children's Mercy Hospital, Kansas City, MO

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Chronic pain, fibromyalgia, pain management, rehabilitation and sleep disorders

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Pediatric Rheumatology – Clinical and Therapeutic Aspects - Poster III: Systemic JIA, Autoinflammatory Syndromes, Scleroderma, Vasculitis, Miscellaneous

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Sleep disorders and fatigue are common in children with chronic pain syndromes, and contributes to psychosocial dysfunction, healthcare utilization, and school absences. We hypothesize that pediatric patients with chronic pain who are treated in an interdisciplinary pain rehabilitation program (IPRP) will have significant self-report of fatigue and sleep disturbance at baseline that will be corroborated by physiological evidence using actigraphy. We postulate that self-report measures and sleep physiology will improve after program completion.

Methods: This is a prospective longitudinal study of adolescents with chronic pain who completed an IPRP. This outpatient program provides daily intensive physical and occupational therapy, sleep education, self-regulation training, and behavioral health intervention.  All pain and sleep medications are discontinued prior to program entry. 20 patients (16 female) age 12-18 with chronic musculoskeletal pain were evaluated at baseline, weekly during treatment, and again at 1-month after program completion by self-report PROMIS measures of fatigue and sleep disturbance (including items assessing sleep satisfaction and insomnia), and by actigraphy using Motionlogger watches. Paired samples t-tests were conducted with SPSS (V.23) and supplemented with hierarchical linear modeling (HLM7) for time-series analyses.

Results: Participants report difficulty falling asleep at baseline with insomnia score of 3.15 on a scale of 1 to 5. They are unsatisfied with sleep, with a score of 2.80. Both insomnia and sleep satisfaction significantly improve by program end (P<0.001), with continued improvement to 1.29 and 4.39 (P<0.001), respectively at 1-month follow-up. At baseline, patients report high daytime fatigue 24.30 on a scale of 0 to 40 and sleep disturbance 31.65 on a scale of 8 to 40. Both of these measures improved significantly, with fatigue changing from significantly impaired to normal (8.43, P<0.001) at 1-month follow-up. Actigraphy showed improvement in total minutes asleep after the first week (P=.02) and this was maintained at program end (P=.03), but not in the weeks after the program (P=.21).  Sleep efficiency, sleep latency, and duration of first sleep episode did not show significant change during the program.

Conclusion: Children with chronic musculoskeletal pain report severe sleep impairments prior to starting an intensive pain rehabilitation program. Following the program they report significant improvements with insomnia, sleep satisfaction, daytime fatigue, and sleep disturbance. Despite statistically significant change in all patient-reported outcomes, these findings are not mirrored by objective data using actigraphy. Long-term follow-up and a larger sample size is needed to determine whether these outcomes will eventually more closely match patient report, or whether subjective issues are the most important improvement.

 


Disclosure: C. Hoffart, None; S. Fortney, None; D. Wallace, None.

To cite this abstract in AMA style:

Hoffart C, Fortney S, Wallace D. Sleep Disruption in Children with Chronic Pain [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/sleep-disruption-in-children-with-chronic-pain/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sleep-disruption-in-children-with-chronic-pain/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology